Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. China Artificial Organs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Organ Type (Artificial Heart (Prosthetic Heart Valves, Ventricular Assist Devices, Cardiac Pacemakers), Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Others)
5.2.2. By Technology (Electronic Bionics, Mechanical)
5.2.3. By Material Type (Silicon, Plastic, Metal)
5.2.4. By Company (2022)
5.2.5. By Region
5.3. Market Map
6. China Silicon Based Artificial Organs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Organ Type
6.2.2. By Technology
7. China Plastics Based Artificial Organs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Organ Type
7.2.2. By Technology
8. China Metal Based Artificial Organs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Organ Type
8.2.2. By Technology
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Development
11. Policy & Regulatory Landscape
12. China Economic Profile
13. Competitive Landscape
13.1. Competition Outlook (Top Companies)
13.1.1. Chengdu Baishixing Science & Technology Industry Co Ltd
13.1.2. Regenovo Biotechnology
13.1.3. Abiomed Inc.
13.1.4. Cyfuse Biomedical
13.1.5. Nipro Corporation
13.1.6. Medtronic Inc.
13.1.7. Boston Scientific Corporation
13.1.8. Terumo Corporation
13.1.9. Tibion Corporation
13.1.10. Baxter International Inc.
14. Strategic Recommendations